gene2lead logo

About us

At Gene2Lead, we incorporate AI-based computational pipelines to existing medicinal chemistry-based drug discovery programs.

We are developing an AI-integrated platform technology that unmasks difficult drug targets and generates therapeutics against them, revealing high-value and previously inaccessible biomolecule targets that can potentially be applied to a range of diseases.

Our platform offers drug discovery programs with comprehensive structural insights for identifying druggable binding sites protein protein-analyzing ligand binding modes and computationally generating rational drug design ideas in a robust scale-up and expedited fashion. We receive client projects at the level of a target gene of interest and work it through a semi-automated customized high throughput project pipeline to identify novelty lead drug molecules for experimental testing.

Program engagement



Patrick Gunning


Elvin de Araujo

Operations Advisor

Serap Beldar

Scientific and Marketing Consultant


Intellectual Property